281 related articles for article (PubMed ID: 23122225)
1. The effects of electrical stimulation exercise on muscles injected with botulinum toxin type-A (botox).
Fortuna R; Horisberger M; Vaz MA; Van der Marel R; Herzog W
J Biomech; 2013 Jan; 46(1):36-42. PubMed ID: 23122225
[TBL] [Abstract][Full Text] [Related]
2. Do skeletal muscle properties recover following repeat onabotulinum toxin A injections?
Fortuna R; Horisberger M; Vaz MA; Herzog W
J Biomech; 2013 Sep; 46(14):2426-33. PubMed ID: 23953503
[TBL] [Abstract][Full Text] [Related]
3. Changes in contractile properties of muscles receiving repeat injections of botulinum toxin (Botox).
Fortuna R; Vaz MA; Youssef AR; Longino D; Herzog W
J Biomech; 2011 Jan; 44(1):39-44. PubMed ID: 20828699
[TBL] [Abstract][Full Text] [Related]
4. Botox produces functional weakness in non-injected muscles adjacent to the target muscle.
Yaraskavitch M; Leonard T; Herzog W
J Biomech; 2008; 41(4):897-902. PubMed ID: 18184613
[TBL] [Abstract][Full Text] [Related]
5. A clinically relevant BTX-A injection protocol leads to persistent weakness, contractile material loss, and an altered mRNA expression phenotype in rabbit quadriceps muscles.
Fortuna R; Vaz MA; Sawatsky A; Hart DA; Herzog W
J Biomech; 2015 Jul; 48(10):1700-6. PubMed ID: 26087882
[TBL] [Abstract][Full Text] [Related]
6. Effects of β-hydroxy-β-methylbutyrate supplementation on muscle mass and strength in onabotulinumtoxin type-A-injected and contralateral quadriceps femoris in rabbits.
Fortuna R; Sawatsky A; Fuller JC; Herzog W
J Rehabil Med; 2021 Sep; 53(9):jrm00229. PubMed ID: 34430979
[TBL] [Abstract][Full Text] [Related]
7. Acute botulinum toxin-induced muscle weakness in the anterior cruciate ligament-deficient rabbit.
Longino D; Frank C; Herzog W
J Orthop Res; 2005 Nov; 23(6):1404-10. PubMed ID: 15913943
[TBL] [Abstract][Full Text] [Related]
8. Proposed model of botulinum toxin-induced muscle weakness in the rabbit.
Longino D; Frank C; Leonard TR; Vaz MA; Herzog W
J Orthop Res; 2005 Nov; 23(6):1411-8. PubMed ID: 15935608
[TBL] [Abstract][Full Text] [Related]
9. The role of muscles in joint degeneration and osteoarthritis.
Herzog W; Longino D
J Biomech; 2007; 40 Suppl 1():S54-63. PubMed ID: 17434520
[TBL] [Abstract][Full Text] [Related]
10. Effect of muscle activity and botulinum toxin dilution volume on muscle paralysis.
Kim HS; Hwang JH; Jeong ST; Lee YT; Lee PK; Suh YL; Shim JS
Dev Med Child Neurol; 2003 Mar; 45(3):200-6. PubMed ID: 12613778
[TBL] [Abstract][Full Text] [Related]
11. Muscle weakness causes joint degeneration in rabbits.
Rehan Youssef A; Longino D; Seerattan R; Leonard T; Herzog W
Osteoarthritis Cartilage; 2009 Sep; 17(9):1228-35. PubMed ID: 19427403
[TBL] [Abstract][Full Text] [Related]
12. Effect of a single botulinum toxin injection on bone development in growing rabbits.
Rauch F; Hamdy R
J Musculoskelet Neuronal Interact; 2006; 6(3):264-8. PubMed ID: 17142948
[TBL] [Abstract][Full Text] [Related]
13. Effects of botulinum toxin type A on non-injected bi-articular muscle include a narrower length range of force exertion and increased passive force.
Ateş F; Yucesoy CA
Muscle Nerve; 2014 Jun; 49(6):866-78. PubMed ID: 24122931
[TBL] [Abstract][Full Text] [Related]
14. Effects of botulinum toxin A injection and exercise on the growth of juvenile rat gastrocnemius muscle.
Chen CM; Stott NS; Smith HK
J Appl Physiol (1985); 2002 Oct; 93(4):1437-47. PubMed ID: 12235045
[TBL] [Abstract][Full Text] [Related]
15. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
16. BTX-A has notable effects contradicting some treatment aims in the rat triceps surae compartment, which are not confined to the muscles injected.
Yucesoy CA; Ateş F
J Biomech; 2018 Jan; 66():78-85. PubMed ID: 29154085
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin-A injections via electrical motor point stimulation to treat writer's cramp: pilot study.
Lim EC; Quek AM; Seet RC
Neurol Neurophysiol Neurosci; 2006 Jun; ():4. PubMed ID: 17260081
[TBL] [Abstract][Full Text] [Related]
18. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot.
Mancini F; Sandrini G; Moglia A; Nappi G; Pacchetti C
Neurol Sci; 2005 Apr; 26(1):26-31. PubMed ID: 15877184
[TBL] [Abstract][Full Text] [Related]
19. Frequency and length-dependent effects of Botulinum toxin-induced muscle weakness.
Longino D; Butterfield TA; Herzog W
J Biomech; 2005 Mar; 38(3):609-13. PubMed ID: 15652561
[TBL] [Abstract][Full Text] [Related]
20. Effect of botulinum toxin A-induced paralysis and exercise training on mechanosensing and signalling gene expression in juvenile rat gastrocnemius muscle.
Velders M; Legerlotz K; Falconer SJ; Stott NS; McMahon CD; Smith HK
Exp Physiol; 2008 Dec; 93(12):1273-83. PubMed ID: 18603602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
